HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans J Hansen Selected Research

Hans J Hansen Research Topics

Disease

23Neoplasms (Cancer)
10/2009 - 05/2002
9Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2009 - 08/2003
6Lymphoma (Lymphomas)
01/2009 - 05/2002
5Colonic Neoplasms (Colon Cancer)
11/2008 - 04/2005
3B-Cell Lymphoma (Lymphoma, B Cell)
02/2008 - 05/2002
3Burkitt Lymphoma (Burkitt's Lymphoma)
02/2008 - 12/2005
3Multiple Myeloma
09/2007 - 12/2004
3Neoplasm Metastasis (Metastasis)
01/2007 - 04/2005
2Carcinoma (Carcinomatosis)
10/2009 - 04/2005
1Multiple Sclerosis
01/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2009
1Autoimmune Diseases (Autoimmune Disease)
02/2007
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2007
1Prostatic Neoplasms (Prostate Cancer)
01/2007
1Neoplasm Micrometastasis
10/2005
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2005
1Residual Neoplasm
04/2005
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2004
1Breast Neoplasms (Breast Cancer)
03/2004
1Hematologic Neoplasms (Hematological Malignancy)
05/2002

Drug/Important Bio-Agent (IBA)

12Monoclonal AntibodiesIBA
09/2007 - 05/2002
10AntigensIBA
11/2008 - 01/2003
7AntibodiesIBA
02/2008 - 05/2002
7Radioisotopes (Radionuclides)IBA
09/2007 - 05/2002
6Peptides (Polypeptides)IBA
01/2012 - 05/2002
6Carcinoembryonic AntigenIBA
01/2007 - 09/2003
5Pharmaceutical PreparationsIBA
11/2008 - 12/2003
4Rituximab (Mabthera)FDA Link
01/2009 - 04/2004
4epratuzumabIBA
02/2007 - 08/2003
3Irinotecan (Camptosar)FDA LinkGeneric
10/2009 - 04/2005
3Immunoconjugates (Immunoconjugate)IBA
10/2009 - 07/2005
3Complement System Proteins (Complement)IBA
01/2009 - 04/2004
3Ribonucleases (Ribonuclease)IBA
09/2007 - 05/2002
3HaptensIBA
11/2005 - 09/2003
3Proteins (Proteins, Gene)FDA Link
10/2005 - 09/2003
2ProdrugsIBA
10/2009 - 11/2008
2veltuzumabIBA
01/2009 - 04/2004
2labetuzumabIBA
11/2008 - 04/2005
2milatuzumabIBA
09/2007 - 12/2004
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2007 - 07/2005
2HLA-DR Antigens (HLA-DR)IBA
10/2006 - 07/2005
2Immunotoxins (Immunotoxin)IBA
12/2005 - 05/2005
2Immunoglobulin G (IgG)IBA
12/2005 - 04/2005
2IodineIBA
04/2005 - 03/2004
2chloramine-T (Clorina)IBA
03/2004 - 01/2003
1Topoisomerase I InhibitorsIBA
11/2008
1BuffersIBA
11/2008
1IsotopesIBA
09/2007
1EpitopesIBA
10/2005
1IMMU-110IBA
07/2005
1Humanized Monoclonal AntibodiesIBA
05/2005
1Fluorouracil (Carac)FDA LinkGeneric
04/2005
1Biological ProductsIBA
04/2005
1ORALIT (ORS)IBA
08/2004
1Floxuridine (FUdR)FDA LinkGeneric
01/2004
1Drug CarriersIBA
01/2004
1LigandsIBA
01/2004
1LipidsIBA
01/2004
1Indicators and Reagents (Reagents)IBA
01/2004
1AnthracyclinesIBA
12/2003
1AcidsIBA
09/2003
1Bispecific AntibodiesIBA
05/2002
1RNA (Ribonucleic Acid)IBA
05/2002
1Surface Antigens (Surface Antigen)IBA
05/2002

Therapy/Procedure

16Therapeutics
10/2009 - 05/2002
4Drug Therapy (Chemotherapy)
10/2009 - 04/2005
3Radioimmunotherapy
08/2005 - 03/2004
2Immunotherapy
02/2008 - 09/2007
1Treatment Delay
12/2005